Reynold A. Panettieri Jr., MD, elaborates on the risks of lung damage resulting from exacerbations, with a focus on the role of type 2 inflammation in triggering these events.
What are the long-term effects of persistent type 2 inflammation on lung function of patients living with asthma or COPD?
What impact does type 2 inflammation have on exacerbation and hospitalization rates in these diseases? How does type 2 inflammation affect disease progression?